Skip to main content

Table 1 Characteristics of the 95 patients taking part in the study

From: Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care

  Asthma n(%) COPD/Both n(%) All n(%)
All 46 (48.4) 49 (51.6) 95 (100)
Age 65 years or more 17 (37.0) 28 (57.1) 45 (47.4)
Gender    
Male 17 (37.0) 18 (36.7) 35 (36.8)
Female 29 (63.0) 31 (63.3) 60 (63.2)
Smoking status    
Never smoker 18 (39.1) 8 (16.3) 26 (27.4)
Current smoker 12 (26.1) 18 (36.7) 30 (31.6)
Ex-smoker 16 (34.8) 23 (46.9) 39 (41.1)
Spirometry at baseline    
FEV1/FVC < 0.7 7 (15.2) 32 (65.3) 39 (41.1)
Respiratory symptoms    
Dyspnea, bothersome or very bothersome 42 (91.3) 47 (95.9) 89 (93.7)
very bothersome 12 (26.1) 19 (38.8) 31 (32.6)
Phlegm, bothersome or very bothersome 35 (76.1) 36 (73.5) 71 (74.7)
very bothersome 9 (19.6) 9 (18.4) 18 (18.9)
Purulence 23 (50.0) 21 (42.9) 44 (46.3)
Coughing, bothersome or very bothersome 42 (91.3) 43 (87.8) 85 (89.5)
very bothersome 16 (34.8) 15 (30.6) 31 (32.6)
Chest findings    
Prolonged expiration 16 (34.8) 26 (53.1) 42 (44.2)
Wheezes/rhonchi 16 (34.8) 31 (63.3) 47 (49.5)
Diminished breath sounds 4 (8.7) 15 (30.6) 19 (20.0)
Crackles 10 (21.7) 18 (36.7) 28 (29.5)
Any abnormal chest finding 24 (52.2) 39 (79.6) 63 (66.3)
Admitted to hospital due to exacerbation the year before baseline 3 (6.6) 3 (6.1) 6 (6.4)
Exacerbation treated with antibiotics the year before baseline 13 (28.3) 24 (49.0) 37 (38.9)
Exacerbation treated with systemic corticosteroids the year before baseline 7 (15.2) 24 (49.0) 31 (32.6)